Huiling Pei
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 30
- Multiple Myeloma Research and Treatments 30
-
- Protein Degradation and Inhibitors 6
- Amyloidosis: Diagnosis, Treatment, Outcomes 5
- Co-authors
- Michel Marre (1 shared paper)Éric Renard (1 shared paper)Bruce W. Bode (1 shared paper)Satish K. Garg (1 shared paper)Miles Fisher (1 shared paper)John B. Buse (1 shared paper)Ludwig Merker (1 shared paper)Areti Philotheou (1 shared paper)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (6 papers)HemaSphere (3 papers)Blood Advances (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Huiling Pei
41 papers receiving 612 citations
Peers
Comparison fields: 5 of 57
- Endocrinology, Diabetes and Metabolism 292
- Hematology 197
- Oncology 110
- Surgery 132
- Genetics 26
Countries citing papers authored by Huiling Pei
This map shows the geographic impact of Huiling Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiling Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiling Pei more than expected).
Fields of papers citing papers by Huiling Pei
This network shows the impact of papers produced by Huiling Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiling Pei. The network helps show where Huiling Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Huiling Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 318 | |
| 2 | 2019 | 35 | |
| 3 | 2018 | 32 | |
| 4 | 2019 | 28 | |
| 5 | 2019 | 26 | |
| 6 | 2018 | 21 | |
| 7 | 2020 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 14 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 11 | |
| 12 | 2023 | 11 | |
| 13 | 2018 | 9 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2023 | 6 | |
| 17 | 2018 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2022 | 5 |
About Huiling Pei
Huiling Pei is a scholar working on Hematology, Molecular Biology, Oncology, Organic Chemistry and Genetics, having authored 43 papers that have together received 642 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (30 papers), Synthesis and Biological Evaluation (7 papers), Protein Degradation and Inhibitors (6 papers), Cancer Treatment and Pharmacology (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (292 citations), Hematology (197 citations), Oncology (110 citations), Surgery (132 citations) and Genetics (26 citations). Huiling Pei has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Michel Marre, Éric Renard, Bruce W. Bode, Satish K. Garg, Miles Fisher, John B. Buse, Ludwig Merker, Areti Philotheou, David Russell‐Jones and Simon Heller. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Blood Advances and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.